Unknown

Dataset Information

0

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.


ABSTRACT: Drug-induced cardiotoxicity is the leading cause of drug attrition and withdrawal from the market. Therefore, using appropriate preclinical cardiac safety assessment models is a critical step during drug development. Currently, cardiac safety assessment is still highly dependent on animal studies. However, animal models are plagued by poor translational specificity to humans due to species-specific differences, particularly in terms of cardiac electrophysiological characteristics. Thus, there is an urgent need to develop a reliable, efficient, and human-based model for preclinical cardiac safety assessment. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as an invaluable in vitro model for drug-induced cardiotoxicity screening and disease modeling. hiPSC-CMs can be obtained from individuals with diverse genetic backgrounds and various diseased conditions, making them an ideal surrogate to assess drug-induced cardiotoxicity individually. Therefore, methodologies to comprehensively investigate the functional characteristics of hiPSC-CMs need to be established. In this protocol, we detail various functional assays that can be assessed on hiPSC-CMs, including the measurement of contractility, field potential, action potential, and calcium handling. Overall, the incorporation of hiPSC-CMs into preclinical cardiac safety assessment has the potential to revolutionize drug development.

SUBMITTER: Zhao SR 

PROVIDER: S-EPMC9668591 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Zhao Shane Rui SR   Mondéjar-Parreño Gema G   Li Dong D   Shen Mengcheng M   Wu Joseph C JC  

Journal of visualized experiments : JoVE 20220804 186


Drug-induced cardiotoxicity is the leading cause of drug attrition and withdrawal from the market. Therefore, using appropriate preclinical cardiac safety assessment models is a critical step during drug development. Currently, cardiac safety assessment is still highly dependent on animal studies. However, animal models are plagued by poor translational specificity to humans due to species-specific differences, particularly in terms of cardiac electrophysiological characteristics. Thus, there is  ...[more]

Similar Datasets

| S-EPMC5430511 | biostudies-literature
| S-EPMC5099952 | biostudies-literature
| S-EPMC9477872 | biostudies-literature
| S-EPMC10095337 | biostudies-literature
| S-EPMC1808333 | biostudies-literature
| S-EPMC3781326 | biostudies-literature
| S-EPMC4942673 | biostudies-literature
| S-EPMC5421571 | biostudies-literature
| S-EPMC5404656 | biostudies-literature
| S-EPMC11920353 | biostudies-literature